By Eva Richardson | The Logistic News
April 11, 2025
As the pharmaceutical industry contends with mounting pressure for resilience, compliance, and sustainability, global leaders are set to converge in Basel, Switzerland this May for a critical forum that promises to reshape how the sector moves, monitors, and secures its products. The Pharma Supply Chain & Logistics Innovation Programme 2025, scheduled for May 27–28 at the Mövenpick Hotel Basel, will bring together top executives, supply chain strategists, and technology innovators from across the life sciences logistics spectrum.
Hosted by the World BI Group, the two-day summit is expected to serve as a springboard for next-generation logistics strategy, spotlighting everything from real-time visibility and AI integration to temperature-sensitive cargo and ESG-aligned infrastructure.
Basel: A Natural Stage for Pharma’s Supply Chain Revolution
Long regarded as a hub of pharmaceutical innovation, Basel provides a symbolic and strategic setting for this year’s summit. Home to major industry players like Novartis and Roche, the city is well-placed at the crossroads of Europe’s drug manufacturing and distribution corridors—making it the ideal venue to tackle global supply chain bottlenecks and compliance shifts.
“The 2025 Programme in Basel isn’t just another event—it’s a working summit for change,” said Sonia Albrecht, senior advisor at Pharmalogic Strategies. “What’s on the table are real solutions to the industry’s most urgent problems: risk mitigation, traceability, and digitalization.”
From Cold Chain to AI: Key Themes Shaping the Future
The agenda, curated with input from regulatory bodies, pharmaceutical manufacturers, and third-party logistics providers (3PLs), spans a wide range of pressing topics:
-
Real-Time Risk & Compliance Management: Navigating a rapidly evolving global regulatory landscape, including serialization mandates, import/export controls, and GxP standards.
-
Technology-Driven Transformation: Showcasing how blockchain, AI, and IoT sensors are being deployed to ensure shipment integrity, monitor conditions in-transit, and automate validation processes.
-
Advanced Cold Chain Logistics: Addressing the engineering and environmental challenges of transporting temperature-sensitive biologics, vaccines, and gene therapies at scale.
-
Sustainable Logistics Models: Exploring carbon-reduction strategies, green warehousing, reusable packaging systems, and how ESG targets are driving procurement and distribution reforms.
-
Case-Based Insight Sharing: Sessions will feature real-world perspectives from companies like Takeda, Zentiva, SK Pharma, and Apellis, focusing on practical applications rather than theory.
Industry Voices: Leading the Conversation
Among the notable confirmed speakers:
-
Robert Pławiak, CDIO/CTO, Polpharma
-
Silvia Garcia Gonzalez, Head of Logistics & Network Performance, Takeda Vaccines
-
Doron Azran, Head of Global Supply Chain, SK Pharma
-
Stefan Ibing, Head of Legal International Commercial, Apellis
-
Sapan Gandhi, Head of Materials Procurement, Zentiva
These voices will shape forward-looking conversations on how pharmaceutical supply chains must adapt to global disruptions, talent shortages, and technological shifts.
Beyond the Talks: A Platform for Real Collaboration
More than just a thought leadership event, the Innovation Programme is designed to foster meaningful cross-industry collaboration. Delegates will have access to curated networking sessions, private roundtables, and B2B matchmaking—all with the goal of building actionable partnerships across pharma, logistics, and tech sectors.
Notably, the event also incorporates a sustainability initiative, pledging to plant one tree per attendee in developing countries to offset emissions generated by the conference.
Why It Matters: With drug safety, traceability, and speed-to-market now inextricably linked, logistics is no longer a backend function—it’s a critical driver of pharmaceutical performance and patient outcomes. As the industry eyes a new post-pandemic equilibrium, forums like the Basel Innovation Programme may set the tone for how the next decade of pharma logistics will take shape.
Eva Richardson is a senior correspondent for The Logistic News, covering pharmaceutical logistics, global health supply chains, and sustainability in life sciences operations.
